How Often Should You Get a Calcium Score Test?

For most people without symptoms, a single coronary artery calcium (CAC) scan is the starting point, and if that score comes back at zero, you can generally wait somewhere between three and seven years before repeating it. The exact interval depends on your age, sex, ethnicity, and risk factors. Repeat testing after a positive score is a different question entirely, and the answer there is less encouraging for fans of frequent scanning. Guidelines and the underlying science paint a more nuanced picture than “get one every year,” and in some cases a second scan adds little useful information beyond what you already know.

What a Zero Score Buys You

A calcium score of zero is one of the most reassuring results in cardiovascular medicine. It means no detectable calcified plaque in your coronary arteries at the time of the scan, and it carries strong negative predictive value for heart attacks and other major events. The practical question is how long that reassurance lasts. A large analysis using data from the Multi-Ethnic Study of Atherosclerosis (MESA) estimated the “warranty period” of a zero score at roughly three to seven years, depending on sex and race or ethnicity, before the likelihood of a new positive result becomes high enough to make rescanning worthwhile.

That range is wide because plaque develops at different speeds in different people. In the MESA data, men and certain racial and ethnic groups tended to transition from zero to a detectable score faster, which shortened the warranty period toward the three-year end. Women without major risk factors often fell closer to the seven-year end.¹ If you scored zero and your risk profile hasn’t changed dramatically, repeating the scan in four to five years is a reasonable middle ground for most people. If your doctor views you as low-risk, waiting longer is defensible.

Why Repeating After a Positive Score Is Less Useful

Once calcium shows up, you might assume that tracking its progression would help guide treatment. Intuitively it makes sense: if the number goes up, try harder; if it stabilizes, stay the course. But multiple prospective trials have looked at exactly this and found that repeat scans in people with a positive score haven’t reliably changed treatment decisions or outcomes. The calcium score tends to climb with age in almost everyone, whether or not they are on medication, and no clinical algorithm currently exists for adjusting therapy based on how fast the number rises.²

A further complication is that statins, the most commonly prescribed drugs for people with elevated cardiovascular risk, actually increase calcium scores over time. This sounds alarming but reflects a shift in plaque composition rather than worsening disease. Statin therapy has been shown to shrink the soft, fatty components of plaque while promoting denser, more stable calcification.³ That denser calcium is actually associated with a lower risk of adverse events, even though the headline score goes up.⁴ So a rising score in someone taking a statin can mean the drug is working, not failing. This makes serial tracking of the number misleading for patients and clinicians alike, and it is one of the main reasons guideline bodies have generally discouraged routine repeat scanning in people already known to have coronary calcium.

What the Score Actually Tells You About Risk

Coronary artery calcium is not a passive byproduct of aging. It is an active process driven by the same inflammatory pathways behind atherosclerosis, the buildup of plaque in artery walls.⁵ The Agatston score quantifies the total calcium burden across all coronary arteries, and it sorts people into risk categories that are surprisingly powerful. In the Walter Reed Cohort Study, people with scores above 400 had roughly six times the risk of heart attack and about double the risk of death compared to those with no calcium, after adjusting for standard risk factors.⁶

The score also predicts stroke, though the association is not as dramatic as it is for heart attack. A meta-analysis found that people with scores above 100 had roughly two and a half times the risk of stroke compared to those with no calcium.⁷ These risk estimates hold up in younger adults too. Among people under 45 or 50, any detectable calcium has been associated with roughly triple the risk of heart attack over about a decade of follow-up, and scores above 100 carried particularly steep risk.⁸

These numbers explain why the test is valued as a tiebreaker. When traditional risk calculators place you in a gray zone, a calcium score can bump you into a category that changes management. A meta-analysis of studies evaluating the calcium score on top of standard risk models found that it improved discrimination meaningfully, reclassifying a quarter of patients into more appropriate risk categories.⁹ A more recent analysis confirmed a similar pattern and also showed that the calcium score outperformed polygenic risk scores for predicting coronary heart disease events.¹⁰

When to Get Your First Scan

Major guidelines, including the 2019 ACC/AHA primary prevention guideline, recommend considering a calcium score when a treatment decision is uncertain, particularly for people whose 10-year cardiovascular risk falls in the intermediate range (roughly 5 to 20 percent). If risk calculators already put you at high risk, or you already have known heart disease, the scan won’t change management and you don’t need one. If you’re clearly low risk, the yield is too low to justify it routinely.

The question of age is less settled. Modeling based on MESA data has tried to estimate the optimal age for a first scan among at-risk adults. For men with diabetes, the estimated ideal age for a first scan was around 37 years; for women with diabetes, around 50. For men and women without traditional risk factors, those ages were roughly 42 and 58, respectively.¹¹ These figures aren’t hard rules. They reflect the age at which enough people in each group will have transitioned to a positive score to make the scan informative rather than a waste of time and radiation.

Younger adults under 40 or 45 are generally not screened routinely, but the presence of even a small amount of calcium at that age carries disproportionate weight. About one in ten young adults in the general population, and roughly one in three young adults with risk factors like diabetes, smoking, or high cholesterol, already have detectable calcium.¹² Finding calcium at a young age is a strong signal for early intervention with lifestyle changes and possibly medication. In a younger population studied in China (ages 30 to 50), combining the calcium score with traditional risk factors predicted obstructive coronary disease more accurately than standard risk models alone.¹³

How Sex and Ethnicity Shift the Timeline

Men develop coronary calcium earlier, accumulate more of it, and progress faster than women. Data from MESA showed that men had higher calcium levels than women across every age bracket, and that racial and ethnic differences further modified these patterns.¹⁴ Vessel-by-vessel, men carried roughly two to three times as much calcium as women even after adjusting for other cardiovascular risk factors, and the odds of a score above 100 were more than three and a half times greater in men.¹⁵

Calcium also progresses faster in men, though the gap narrows as overall risk climbs. A large Korean registry found that almost half of men but fewer than a third of women showed meaningful calcium progression over five years. Among people in the lowest risk category, the sex gap was wide: about 38 percent of men progressed compared to 18 percent of women. But at higher risk levels, the gap shrank and nearly disappeared.¹⁶ The practical upshot is that men with risk factors may need earlier first scans and shorter intervals before rescreening, while lower-risk women can typically wait longer before a repeat test would be worthwhile.

The Behavioral Power of Seeing Your Score

One underappreciated reason to consider the test is what it does to motivation. Unlike blood pressure or cholesterol numbers, a calcium scan produces an image of your actual arteries. People who see evidence of plaque in their own bodies tend to take prevention more seriously. A systematic review of studies on the behavioral effects of calcium screening found that in 13 of 15 studies, seeing a score improved medication adherence, and there was suggestive evidence of lifestyle improvements as well.¹⁷

The relationship is dose-dependent in a psychologically interesting way. People with a zero score were the least likely to stick with statin therapy (roughly 27 percent compliance), while those with scores above 400 were more than twice as likely to keep taking their medication (about 59 percent). Weight loss followed the same pattern: about 20 percent of people with a zero score lost weight after their scan, versus roughly 34 percent of those with the highest scores.¹⁸ An earlier study found an even steeper gradient: people in the highest quartile of calcium scores maintained 91 percent statin adherence compared to 44 percent in the lowest quartile.¹⁹

This cuts both ways. A zero score, while reassuring from a risk standpoint, can undermine the motivation to keep taking prescribed medications or maintain healthy habits. Some clinicians argue this is a valid reason to be thoughtful about who gets scanned and how results are communicated: a zero doesn’t mean zero risk, and it doesn’t mean statins or exercise are unnecessary for everyone who receives one.

Radiation and Cost Concerns

A calcium score scan uses a low-dose CT without contrast dye, and the radiation exposure is modest. In the MESA cohort, the average effective dose was about 1 millisievert per scan, which is roughly equivalent to what you’d receive from a few months of natural background radiation.²⁰ Newer techniques have pushed doses even lower.²¹ The radiation argument against routine repeat scanning is not that any single scan is dangerous, but rather that unnecessary scans accumulate dose without changing clinical decisions.

Cost is a more tangible barrier. The scan itself is typically inexpensive compared to other cardiac imaging, often running between $75 and $200, but it is frequently not covered by insurance. Many commercial insurers and Medicare do not reimburse for calcium scoring in the primary prevention setting, despite guideline endorsements. This means the decision to get a scan often comes down to whether you’re willing to pay out of pocket, and the decision to repeat one is essentially choosing to pay again for information that may or may not change your treatment.

How the Calcium Score Compares to Other Imaging

A calcium score test is not the only way to look at coronary arteries. CT coronary angiography (CTA), which uses contrast dye to visualize the actual lumen of the arteries, provides more detailed information about both calcified and non-calcified plaque and can directly show narrowing. In head-to-head comparisons, CTA has higher overall diagnostic accuracy than the calcium score alone: about 81 percent versus 69 percent for detecting significant blockages in one large meta-analysis.²² CTA also has better prognostic value for predicting major cardiac events when compared directly to calcium scoring.²³

One striking finding from the CTA comparison data: among people with a calcium score of zero, 17 percent still had obstructive coronary artery disease on CTA.²² This is a critical caveat. A zero calcium score is reassuring in asymptomatic screening, but if you have chest pain or symptoms, it does not rule out significant disease. The calcium score captures only the calcified portion of plaque, while soft, non-calcified plaque can still cause dangerous narrowing. CTA requires contrast, more radiation, and higher cost, so it isn’t used as a first-line screening test for asymptomatic people. But it is a natural next step when symptoms are present or when more detailed information is needed.

Artificial Intelligence and the Future of Scoring

The traditional Agatston score condenses all the calcium in your arteries into a single number. That’s useful but crude: it doesn’t distinguish between one large plaque in one artery and many smaller ones spread across several vessels, nor does it account for plaque density or the size of your heart chambers. AI-based analysis of the same CT images is beginning to extract much richer information without requiring any additional scans.

A study applying AI-based plaque characterization to MESA participants found that an AI-enhanced model significantly outperformed the traditional Agatston score for predicting coronary heart disease events. This was especially true in the large group of people with scores between 1 and 100, where the standard score alone is a relatively weak predictor. By factoring in the number of plaques, their location, their density, and cardiac chamber volumes, the AI composite model achieved notably better discrimination over both five- and ten-year follow-up.²⁴ AI-based software is also enabling automated quantification of calcium volume and density, which could eventually replace or supplement the Agatston score as the standard metric.²⁵

If these tools make it into routine clinical use, they could change the repeat-testing calculus. A single scan analyzed with AI might provide enough granular information to guide risk management for years without needing a follow-up scan. Alternatively, if AI can pick out subtle progression in plaque characteristics that the raw Agatston score misses, there might eventually be a meaningful reason to rescan certain patients. For now, this remains a research frontier rather than something your cardiologist would order, but it’s where the field is heading.

When a Repeat Scan Might Actually Make Sense

Despite the general recommendation against routine repeat scanning after a positive result, there are situations where clinicians and patients reasonably consider it. The most common is when someone received a zero score years ago and enough time has passed that a new scan would fall within the warranty period estimates. If your original zero was five or six years ago and you’ve added new risk factors since then, a repeat scan can update your risk profile in a way that’s more concrete than recalculating a Framingham or pooled cohort equation score.

Another scenario involves people who were in the borderline zone at baseline, say a score of 1 to 10, and are making decisions about whether to start a statin or intensify lifestyle changes. While the formal evidence supporting repeat scans in this group is thin, clinicians sometimes use a follow-up scan after several years to see whether the calcium burden has remained stable or climbed. The caveat here is that any progression might reflect statin-driven calcification of previously soft plaque rather than worsening disease, making interpretation tricky.

For people with established high scores who are already on aggressive prevention, the consensus is clearer: repeating the scan adds cost and radiation without actionable information. You already know you have substantial plaque, your treatment is already maximized, and a higher number on a follow-up scan won’t change what you or your doctor do next. In those cases, the most useful follow-up imaging, if any is needed, is usually a CTA or stress test rather than another calcium score.